Discovering new pathways of lymphocyte specification and function
In plain English
AI plain-English summaryThe immune system’s innate lymphoid cells (ILCs) are the body’s first responders, but scientists still don’t fully understand how they specialise into different types that fight infections or repair tissues. This project aims to map the molecular instructions—the environmental signals, surface receptors, and gene-regulating proteins—that turn a generic ILC into a specific subtype with a precise job. When these instructions go wrong, the result is chronic inflammation or autoimmune disease. By decoding the normal pathways of ILC specification, researchers hope to identify new targets for drugs that could dial down unwanted immune reactions without shutting down the entire system. The team will use genetically engineered “polychromILC” mice that make different ILC types glow in distinct colours, combined with CRISPR screens to find new regulators. They will also build a new generation of mouse strains that use Boolean logic—AND, OR, NOT—to control gene edits with surgical precision, avoiding off-target effects. This is fundamental science. It will not produce a treatment tomorrow. But understanding how ILCs are born and deployed is a prerequisite for designing therapies that nudge the immune system back toward balance—a goal that matters for millions of people with asthma, allergies, or inflammatory bowel disease.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Investigator Award in SciencePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know